Key result
Coronary radiation dose linked to ~2.3-fold higher odds of 2-year plaque progression per Gy.
Why the study?
Radiotherapy for breast cancer can increase coronary artery disease risk years later, prompting evaluation of early plaque development and associations with cardiac radiation exposure.
Is cardiac radiation dose during breast cancer radiotherapy associated with the early development of calcified and non-calcified coronary atherosclerotic plaques over 2 years?
Cohort (n=101)
Radiologist blinded to time of scanning (baseline/follow-up) and laterality of radiotherapy
No
Is cardiac radiation dose during breast cancer radiotherapy associated with the early development of calcified and non-calcified coronary atherosclerotic plaques over 2 years?
Coronary CT angiography demonstrates that radiation dose to the left main and circumflex coronary arteries during breast cancer radiotherapy is associated with early development of both calcified and non-calcified coronary plaques within 2 years.
Answers are grounded in this paper and cite their sources.
Coronary dose sparing may warrant consideration in breast radiotherapy; extends prior CAD risk data to early plaque changes but remains hypothesis-generating.
Background—Radiotherapy (RT) for breast cancer (BC) can lead to an increased risk of coronary artery disease several years after RT. The aim of this study was to evaluate the development of overall, non-calcified and calcified atherosclerotic plaques over 2 years after BC for RT and associations with cardiac exposure. Methods—The study included 101 left- or right-sided BC patients treated with RT without chemotherapy. A coronary CT angiography was performed before and 2 years after RT. Plaque development thorough the entire coronary network was defined as an increased number of plaques. Cardiac exposure was quantified with mean doses to the heart, left ventricle, and coronary arteries. Logistic regression models were used to assess association with doses. Results—At inclusion, 37% of patients had plaques, increasing to 42% two years after RT. Overall plaque development was observed in seven patients: five with calcified plaque development and four with non-calcified plaque development. The risk of overall plaque development was significantly associated with doses to the Left Main and Circumflex coronary arteries (OR at 1 Gy = 2.32, p = 0.03 and OR at 1 Gy = 2.27, p = 0.03, respectively). Specific analyses for calcified and non-calcified plaque development showed similar results. Conclusion—Our study suggests an association between coronary arteries exposure and the risk of developing both calcified and non-calcified atherosclerotic plaques over 2 years after BC RT. Trial registration number: NCT02605512.
No takes yet. Share an insight, caveat, or question.
Honaryar et al. (2023) conducted a cohort in Unilateral breast cancer treated with radiotherapy without chemotherapy (n=101). Cardiac radiation exposure during adjuvant 3D conformal breast cancer radiotherapy (specifically mean dose to the left main coronary artery) was evaluated on Overall coronary atherosclerotic plaque development (increase in the number of coronary segments containing any plaque by at least 1 on coronary CT angiography at 2 years) (OR 2.32 per 1 Gy to LMCA, 95% CI 1.08-4.97, p=0.03). Radiation dose to the left main (OR 2.32 per 1 Gy, p=0.03) and circumflex (OR 2.27 per 1 Gy, p=0.03) arteries was associated with 2-year coronary plaque development after breast radiotherapy.
Synapse has enriched 10 related papers. Consider them for comparative context: